Database RASA1base
Version 1.00
File RASA1base.txt
Date 22-Feb-2008
Curator Janita Thusberg
Address Institute of Medical Technology,
Address FI-33014 University of Tampere, Finland
Phone +358-3-3551 8915
Email janita.thusberg@uta.fi
Gene RASA1
Disease Basal Cell Carcinoma
OMIM 608354
Sequence SH2base:RASA1_DNA; EMBL:M23379; UniProt:P20936
Numbering start of the entry
Reference Lappalainen et al., Genome wide analysis of pathogenic
Reference SH2 domain mutations.
Reference Proteins, 2008 Feb 7 [Epub ahead of print]
Reference PMID: 18260110
Funding Finnish acedemy; Instrumentariumin tiedesaatio; Sigrid
Funding Juselius Foundation; European concerted action 'PL963007'
Funding Tampere University Hospital Medical Research Fund
Funding Tampere Graduate School in Biomedicine and Biotechnology
Comments sequence entry reference in every entry;
//
ID R398L(1); standard; MUTATION; SH2_2
Accession A0001
Systematic name g.82417G>T, c.1193G>T, r.1193g>u, p.Arg398Leu
Description A point mutation in the exon 8 leading to an amino acid
Description change in the SH2_2 domain
Date 20-Feb-2008 (Rel. 1, Created)
Date 20-Feb-2008 (Rel. 1, Last updated, Version 1)
RefNumber [1]
RefCrossRef PUBMED; 8275088
RefAuthors Friedman, E., Gejman, P. V., Martin, G. A., McCormick, F.
RefTitle Nonsense mutations in the C-terminal SH2 region of the
RefTitle GTPase activating protein (GAP) gene in human tumours.
RefLoc Nat Genet:242-247 (1993)
Feature dna; 1
Feature /rnalink: 2
Feature /name: point
Feature /loc: SH2base: RASA1_DNA: 82417
Feature /change: g -> t
Feature /genomic_region: exon; 8
Feature rna; 2
Feature /dnalink: 1
Feature /aalink: 3
Feature /name: missense
Feature /loc: EMBL: M23379; GI:182971; M23379: 1311
Feature /codon: cga -> cta; 2
Feature aa; 3
Feature /rnalink: 2
Feature /name: aa substitution
Feature /loc: UniProt: P20936; RASA1_HUMAN: 398
Feature /change: R -> L
Feature /domain: SH2_2
Diagnosis Basal cell carcinoma
//
ID K400E(1); standard; MUTATION; SH2_2
Accession A0002
Systematic name g.82422A>G, c.1198A>G, r.1198a>g, p.Lys400Glu
Description A point mutation in the exon 8 leading to an amino acid
Description change in the SH2_2 domain
Date 20-Feb-2008 (Rel. 1, Created)
Date 20-Feb-2008 (Rel. 1, Last updated, Version 1)
RefNumber [1]
RefCrossRef PUBMED; 8275088
RefAuthors Friedman, E., Gejman, P. V., Martin, G. A., McCormick, F.
RefTitle Nonsense mutations in the C-terminal SH2 region of the
RefTitle GTPase activating protein (GAP) gene in human tumours.
RefLoc Nat Genet:242-247 (1993)
Feature dna; 1
Feature /rnalink: 2
Feature /name: point
Feature /loc: SH2base: RASA1_DNA: 82422
Feature /change: a -> g
Feature /genomic_region: exon; 8
Feature rna; 2
Feature /dnalink: 1
Feature /aalink: 3
Feature /name: missense
Feature /loc: EMBL: M23379; GI:182971; M23379: 1316
Feature /codon: aaa -> gaa; 1
Feature aa; 3
Feature /rnalink: 2
Feature /name: aa substitution
Feature /loc: UniProt: P20936; RASA1_HUMAN: 400
Feature /change: K -> E
Feature /domain: SH2_2
Diagnosis Basal cell carcinoma
//
ID I401V(1); standard; MUTATION; SH2_2
Accession A0003
Systematic name g.82425A>G, c.1201A>G, r.1201a>g, p.Ile401Val
Description A point mutation in the exon 8 leading to an amino acid
Description change in the SH2_2 domain
Date 20-Feb-2008 (Rel. 1, Created)
Date 20-Feb-2008 (Rel. 1, Last updated, Version 1)
RefNumber [1]
RefCrossRef PUBMED; 8275088
RefAuthors Friedman, E., Gejman, P. V., Martin, G. A., McCormick, F.
RefTitle Nonsense mutations in the C-terminal SH2 region of the
RefTitle GTPase activating protein (GAP) gene in human tumours.
RefLoc Nat Genet:242-247 (1993)
Feature dna; 1
Feature /rnalink: 2
Feature /name: point
Feature /loc: SH2base: RASA1_DNA: 82425
Feature /change: a -> g
Feature /genomic_region: exon; 8
Feature rna; 2
Feature /dnalink: 1
Feature /aalink: 3
Feature /name: missense
Feature /loc: EMBL: M23379; GI:182971; M23379: 1319
Feature /codon: ata -> gta; 1
Feature aa; 3
Feature /rnalink: 2
Feature /name: aa substitution
Feature /loc: UniProt: P20936; RASA1_HUMAN: 401
Feature /change: I -> V
Feature /domain: SH2_2
Diagnosis Basal cell carcinoma
//
|